158 related articles for article (PubMed ID: 32408197)
61. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
[TBL] [Abstract][Full Text] [Related]
62. Treatment of NZB/W F1 mice with NZW splenic T cells or with serum of mice experiencing the graft-versus-host reaction: suppression of ongoing anti-double-stranded (ds) DNA antibody formation and improvement of renal function.
Okudaira H; Terada E; Fukuda K; Ito T; Gohda A; Nomura T; Kudo K; Ogita T; Miyamoto T
Clin Immunol Immunopathol; 1984 Sep; 32(3):359-67. PubMed ID: 6331933
[TBL] [Abstract][Full Text] [Related]
63. Autoreactive responses to an environmental factor. 2. Phthalate-induced anti-DNA specificity is downregulated by autoreactive cytotoxic T cells.
Lim SY; Ghosh SK
Immunology; 2004 May; 112(1):94-104. PubMed ID: 15096189
[TBL] [Abstract][Full Text] [Related]
64. The effect of cytokines on the activation-induced apoptosis of B cells in autoimmune NZB x NZW F1 mice.
Chen YY; Suen JL; Wu WM; Chiang BL
Scand J Immunol; 2001 Jun; 53(6):596-601. PubMed ID: 11422908
[TBL] [Abstract][Full Text] [Related]
65. Administration of fasudil, a ROCK inhibitor, attenuates disease in lupus-prone NZB/W F1 female mice.
Stirzaker RA; Biswas PS; Gupta S; Song L; Bhagat G; Pernis AB
Lupus; 2012 May; 21(6):656-61. PubMed ID: 22345122
[TBL] [Abstract][Full Text] [Related]
66. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
67. Loss of epigenetic modifications on the inactive X chromosome and sex-biased gene expression profiles in B cells from NZB/W F1 mice with lupus-like disease.
Syrett CM; Sierra I; Beethem ZT; Dubin AH; Anguera MC
J Autoimmun; 2020 Feb; 107():102357. PubMed ID: 31780316
[TBL] [Abstract][Full Text] [Related]
68. Leptin promotes lupus T-cell autoimmunity.
Amarilyo G; Iikuni N; Shi FD; Liu A; Matarese G; La Cava A
Clin Immunol; 2013 Dec; 149(3):530-3. PubMed ID: 24263282
[TBL] [Abstract][Full Text] [Related]
69. Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4.
Wofsy D; Seaman WE
J Immunol; 1987 May; 138(10):3247-53. PubMed ID: 3106478
[TBL] [Abstract][Full Text] [Related]
70. An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus.
Bahjat FR; Pine PR; Reitsma A; Cassafer G; Baluom M; Grillo S; Chang B; Zhao FF; Payan DG; Grossbard EB; Daikh DI
Arthritis Rheum; 2008 May; 58(5):1433-44. PubMed ID: 18438845
[TBL] [Abstract][Full Text] [Related]
71. Self-reactive T cells in murine lupus: analysis of genetic contributions and development of self-tolerance.
Kotzin BL; Herron LR; Babcock SK; Portanova JP; Palmer E
Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 2):S35-46. PubMed ID: 2571438
[TBL] [Abstract][Full Text] [Related]
72. Genetic control of the spontaneous activation of CD4+ Th cells in systemic lupus erythematosus-prone (NZB x NZW) F1 mice.
Fujii T; Iida Y; Yomogida M; Ikeda K; Haga T; Jikumaru Y; Ninami M; Nishimura N; Kodera Y; Inada Y; Shirai T; Hirose S; Nishimura H
Genes Immun; 2006 Dec; 7(8):647-54. PubMed ID: 17024131
[TBL] [Abstract][Full Text] [Related]
73. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus.
Wen X; Zhang D; Kikuchi Y; Jiang Y; Nakamura K; Xiu Y; Tsurui H; Takahashi K; Abe M; Ohtsuji M; Nishimura H; Takatsu K; Shirai T; Hirose S
Eur J Immunol; 2004 Oct; 34(10):2740-9. PubMed ID: 15368290
[TBL] [Abstract][Full Text] [Related]
74. Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus.
Kansal R; Richardson N; Neeli I; Khawaja S; Chamberlain D; Ghani M; Ghani QU; Balazs L; Beranova-Giorgianni S; Giorgianni F; Kochenderfer JN; Marion T; Albritton LM; Radic M
Sci Transl Med; 2019 Mar; 11(482):. PubMed ID: 30842314
[TBL] [Abstract][Full Text] [Related]
75. Genetic studies on the skin lupus band test in New Zealand mice.
Furukawa F; Maruyama N; Yoshida H; Hamashima Y; Hirose S; Shirai T
Clin Exp Immunol; 1985 Jan; 59(1):146-52. PubMed ID: 3871675
[TBL] [Abstract][Full Text] [Related]
76. pConsensus peptide induces tolerogenic CD8+ T cells in lupus-prone (NZB x NZW)F1 mice by differentially regulating Foxp3 and PD1 molecules.
Singh RP; La Cava A; Hahn BH
J Immunol; 2008 Feb; 180(4):2069-80. PubMed ID: 18250412
[TBL] [Abstract][Full Text] [Related]
77. Responses of B cells from autoimmune mice to IL-5.
Umland SP; Go NF; Cupp JE; Howard M
J Immunol; 1989 Mar; 142(5):1528-35. PubMed ID: 2783944
[TBL] [Abstract][Full Text] [Related]
78. Phenotypic and functional analysis of activated B cells of autoimmune NZB x NZW F1 mice.
Ye YL; Suen JL; Chen YY; Chiang BL
Scand J Immunol; 1998 Feb; 47(2):122-6. PubMed ID: 9496686
[TBL] [Abstract][Full Text] [Related]
79. Peptides based on the complementarity-determining regions of a pathogenic autoantibody mitigate lupus manifestations of (NZB x NZW)F1 mice via active suppression.
Zinger H; Eilat E; Meshorer A; Mozes E
Int Immunol; 2003 Feb; 15(2):205-14. PubMed ID: 12578850
[TBL] [Abstract][Full Text] [Related]
80. Dysregulation of T helper cell cytokines in autoimmune prone NZB x NZW F1 mice.
Lin LC; Chen YC; Chou CC; Hsieh KH; Chiang BL
Scand J Immunol; 1995 Oct; 42(4):466-72. PubMed ID: 7569780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
